文献速递产科母胎医学

预防性抗生素治疗未足月胎膜早破的疗效:系统综述与网状Meta分析

Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-04-23

本系统综述与网状Meta分析纳入23项随机对照试验共7671例未足月胎膜早破孕妇,比较10种抗生素方案的母婴结局。青霉素类显著降低产妇绒毛膜羊膜炎风险(OR 0.46,95%CI 0.27-0.77),克林霉素联合庆大霉素对临床绒毛膜羊膜炎风险降低处于临界显著性(OR 0.16,95%CI 0.03-1.00),克林霉素单用增加母体感染风险,各方案间剖宫产率无显著差异。

要点

  • 青霉素类显著降低产妇绒毛膜羊膜炎风险(OR 0.46,95%CI 0.27-0.77)。
  • 克林霉素联合庆大霉素降低临床绒毛膜羊膜炎风险处于临界显著性(OR 0.16,95%CI 0.03-1.00)。
  • 克林霉素单用增加母体感染风险,各方案间剖宫产率无显著差异。

核心结论

  • 青霉素类仍是降低产妇临床绒毛膜羊膜炎的推荐抗生素方案。
  • 替代方案包括克林霉素联合庆大霉素。
  • 克林霉素不应单独使用。

研究设计与样本

  • 系统综述与网状Meta分析,检索PubMed、Embase和Cochrane Central Register of Controlled Trials自建库至2021年7月20日。
  • 纳入随机对照试验,对象为妊娠37周前未足月胎膜早破孕妇,比较10种抗生素方案中至少2种。
  • 共纳入23项研究,合计7671例孕妇。
  • 采用随机效应模型进行网状Meta分析。

主要发现

  • 青霉素类对产妇绒毛膜羊膜炎的疗效显著优于对照(OR 0.46,95%CI 0.27-0.77)。
  • 克林霉素联合庆大霉素降低临床绒毛膜羊膜炎风险处于临界显著性(OR 0.16,95%CI 0.03-1.00)。
  • 克林霉素单用增加母体感染风险。
  • 各抗生素方案间剖宫产率无显著差异。

关键数值与推荐

  • 推荐青霉素类用于降低产妇临床绒毛膜羊膜炎。
  • 替代方案为克林霉素联合庆大霉素。
  • 克林霉素不应单独使用。

临床怎么用

  • 青霉素类仍为降低产妇临床绒毛膜羊膜炎的推荐抗生素方案。
  • 替代方案包括克林霉素联合庆大霉素。
  • 克林霉素不应单独用于未足月胎膜早破的预防性治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Various prophylactic antibiotic regimens are used in the management of preterm premature rupture of membranes. We investigated the efficacy and safety of these regimens in terms of maternal and neonatal outcomes. DATA SOURCES: We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials from inception to July 20, 2021. STUDY ELIGIBILITY CRITERIA: We included randomized controlled trials involving pregnant women with preterm premature rupture of membranes before 37 weeks of gestation and a comparison of ≥2 of the following 10 antibiotic regimens: control/placebo, erythromycin, clindamycin, clindamycin plus gentamicin, penicillins, cephalosporins, co-amoxiclav, co-amoxiclav plus erythromycin, aminopenicillins plus macrolides, and cephalosporins plus macrolides. METHODS: Two investigators independently extracted published data and assessed the risk of bias with a standard procedure following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Network meta-analysis was conducted using the random-effects model. RESULTS: A total of 23 studies that recruited a total of 7671 pregnant women were included. Only penicillins (odds ratio, 0.46; 95% confidence interval, 0.27-0.77) had significantly superior effectiveness for maternal chorioamnionitis. Clindamycin plus gentamicin reduced the risk of clinical chorioamnionitis, with borderline significance (odds ratio, 0.16; 95% confidence interval, 0.03-1.00). By contrast, clindamycin alone increased the risk of maternal infection. For cesarean delivery, no significant differences were noted among these regimens. CONCLUSION: Penicillins remain the recommended antibiotic regimen for reducing maternal clinical chorioamnionitis. The alternative regimen includes clindamycin plus gentamicin. Clindamycin should not be used alone.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Lin LL, Hung JN, Shiu SI, et al. Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 37094635. doi:10.1016/j.ajogmf.2023.100978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。